pathology-2018-keynote

7 / 7

Research & Reviews: Journal of Medical and Health Sciences
ISSN: 2319-9865
October 08-09, 2018
Edinburgh, Scotland
Pathology 2018
Page 39
17th International Conference on
Pathology & Cancer
Epidemiology
Anew systems approach to diseased states and wellness
result in a new branch in the healthcare services, namely,
personalized medicine (PM). To achieve the implementation
of PM concept, it is necessary to create a fundamentally new
strategy based upon the subclinical recognition of biopredictors
of hidden abnormalities long before the disease clinically
manifests itself. Each decision-maker values the impact of
their decision to use PM on their own budget and well-being,
which may not necessarily be optimal for society as a whole.
It would be extremely useful to integrate data harvesting from
different databanks for applications such as prediction and
personalization of further treatment to thus provide more
tailored measures for the patients resulting in improved patient
outcomes, reduced adverse events, and more cost-effective
use of health care resources. A lack of medical guidelines has
been identified by themajority of responders as the predominant
barrier for adoption, indicating a need for the development of
best practices and guidelines to support the implementation
of PM. Implementation of PM requires a lot before the current
model physician-patient could be gradually displaced by a new
model medical advisor-healthy person-at-risk. This is the reason
for developing global scientific, clinical, social, and educational
projects in the area of PM to elicit the content of the new branch.
Biography
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynas-
ty medical doctors. In 1980, graduated from Astrakhan State Medical Universi-
ty and was awarded with MD. In 1985, Suchkov maintained his PhD as a PhD
student of the I.M. Sechenov MoscowMedical Academy and Institute of Med-
ical Enzymology. In 2001, Suchkov maintained his Doctor Degree at the Na-
tional Institute of Immunology, Russia. From 1989 through 1995, Dr Suchkov
was being a Head of the Lab of Clinical Immunology, Helmholtz Eye Research
Institute in Moscow. From 1995 through 2004 - a Chair of the Dept for Clinical
Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, Dr
Suchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science,
an international journal published jointly by the USSRAcademy of Sciences and
the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, MD, PhD, is:
• Professor, Director, Center for Personalized Medicine, I.M.Sechenov
First Moscow State Medical University and Dept of Clinical Immu-
nology, A.I.Evdokimov Moscow State Medical and Dental University;
• Professor, Chair, Dept for Translational Medicine, Moscow Engineer-
ing Physical Institute (MEPhI), Russia
• Secretary General, United Cultural Convention (UCC), Cambridge,
UK.
Personalized and precision medicine as
a unique avenue to have the healthcare
model renewed to secure the national and
international biosafety
Sergey V Suchkov
Sechenov University, Russia
Sergey V Suchkov, RRJMHS 2018
Volume: 7